AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
The facility is set to be operational by 2029.
AstraZeneca plans $2.02b ADC manufacturing facility in Singapore
This is expected to be operational by 2029.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
Read Here
Advertise
Sign Up
![[Singapore Business Review] Report on the Asian Business Channel](https://www.cmgassets.com/s3fs-public/styles/video_thumbnail/public/2026-10/full-show-thumbnail_1.png.webp?VersionId=bJbrT_JKOuMWBnf7YkmsWjOSWIXddSvY&itok=zWuxHRNG)
Commentary
Singapore’s small exporters need credit that matches their payment cycle
The hidden realities of succession for next-gen heirs
In Asia, fintech leaders must compete on credibility
F1 on a gravel road: Why AI is still stuck in first gear
Why AI blocklists give Singapore firms a false sense of security
When scale arrives before proof: Singapore’s capital allocation question in Southeast Asia
Rethinking fleet ownership in a changing business landscape
Beyond the chips: The materials behind Singapore’s AI infrastructure
How homegrown brands are redefining premium in Asia
AI in hospitality: Where should Singapore’s F&B operators draw the line?